24
Participants
Start Date
August 31, 2001
Primary Completion Date
November 30, 2012
Study Completion Date
June 30, 2016
immuno-ablation and autologous CD34 selected hematopoietic stem cell transplantation (HSCT),
"Stem Cell Mobilization with Cyclophosphamide 4.5 gm/m2 and rhGCSF 10 ug/kg/d x 10 day.~Stem Cell Collection with Cobe Spectra Stem Cell Purification with Miltenyi CliniMACS Stem Cell Transplant Conditioning with Busulphan 9.6 mg/kg iv, Cyclophosphamide 200 mg/kg iv, rabbit ATG 5 mg/kg iv followed by CD34 selected autologous hematopoietic stem cell transplant"
Standard Therapy
Patient will receive standard therapy as decided upon by their treating neurologist.
Ottawa Hospital Research Institute, Ottawa
Lead Sponsor
Multiple Sclerosis Scientific Research Foundation
UNKNOWN
Ottawa Hospital Research Institute
OTHER